Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

599 ARTÍCULOS , VIENDO DEL 586 AL 599

Very-late-onset Friedreich's ataxia: diagnosis in a kindred with late-onset cerebellar ataxia

Fearon C, Lonergan R, Ferguson D, Byrne S, Bradley D, Langan Y, Redmond J.

Pract Neurol. 2020 Feb;20(1):55-58. doi: 10.1136/practneurol-2019-002368. Epub 2019 Aug 29.

First finding of familial spinal cerebellar Ataxia11 in China: clinical, imaging and genetic features

Deng Y, Fu J, Zhong Y, Zhang M, Qi X.

Neurol Sci. 2020 Jan;41(1):155-160. doi: 10.1007/s10072-019-04052-6. Epub 2019 Sep 4.

Whole exome sequencing identifies a homozygous POLG2 missense variant in an adult patient presenting with optic atrophy, movement disorders, premature ovarian failure and mitochondrial DNA depletion

Dosekova P, Dubiel A, Karlowicz A, Zietkiewicz S, Rydzanicz M, Habalova V, Pienkowski VM, Skirkova M, Han V, Mosejova A, Gdovinova Z, Kaliszewska M, Tońska K, Szymanski MR, Skorvanek M, Ploski R.

Eur J Med Genet. 2020 Apr;63(4):103821. doi: 10.1016/j.ejmg.2019.103821. Epub 2019 Nov 26.

The role of the cerebellum in degenerative ataxias and essential tremor: Insights from noninvasive modulation of cerebellar activity

Maas RPPWM, Helmich RCG, van de Warrenburg BPC.

Mov Disord. 2020 Feb;35(2):215-227. doi: 10.1002/mds.27919. Epub 2019 Dec 10.

Management of Alternating Hemiplegia of Childhood: A Review

Samanta D.

Pediatr Neurol. 2020 Feb;103:12-20. doi: 10.1016/j.pediatrneurol.2019.10.003. Epub 2019 Nov 1.

VPS13D-related disorders presenting as a pure and complicated form of hereditary spastic paraplegia

Koh K, Ishiura H, Shimazaki H, Tsutsumiuchi M, Ichinose Y, Nan H, Hamada S, Ohtsuka T, Tsuji S, Takiyama Y.

Mol Genet Genomic Med. 2020 Mar;8(3):e1108. doi: 10.1002/mgg3.1108. Epub 2019 Dec 26.

Zebrafish as a Model System for the Study of Severe Ca(V)2.1 (α(1A)) Channelopathies

Tyagi S, Ribera AB, Bannister RA.

Front Mol Neurosci. 2020 Feb 7;12:329. doi: 10.3389/fnmol.2019.00329. eCollection 2019.

The level of evidence of medical marijuana use for treating disabilities: a scoping review

Stetten N, Pomeranz J, Moorhouse M, Yurasek A, Blue AV.

Disabil Rehabil. 2020 May;42(9):1190-1201. doi: 10.1080/09638288.2018.1523952. Epub 2018 Nov 20.

Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015

Schneider M, Regente J, Greiner T, Lensky S, Bleich S, Toto S, Grohmann R, Stübner S, Heinze M.

Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):23-33. doi: 10.1007/s00406-018-0959-2. Epub 2018 Nov 30.

Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications

Yoshida K, Müller DJ.

Mol Neuropsychiatry. 2020 Apr;5(Suppl 1):1-26. doi: 10.1159/000492332. Epub 2018 Sep 26.

Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group

Leite CMBA, Schieferdecker MEM, Frehner C, Munhoz RP, Ashizawa T, Teive HAG.

Nutr Neurosci. 2020 Jan;23(1):49-54. doi: 10.1080/1028415X.2018.1469282. Epub 2018 May 7.

Congenital Mirror Movements

Méneret A, Trouillard O, Dunoyer M, Depienne C, Roze E.

2015 Mar 12 [updated 2020 Sep 24]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

CASK Disorders

Moog U, Kutsche K.

2013 Nov 26 [updated 2020 May 21]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Allan-Herndon-Dudley Syndrome

Sarret C, Oliver Petit I, Tonduti D.

2010 Mar 9 [updated 2020 Jan 16]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias